Park S, Kim YJ, Min YJ, Mortimer PGS, et al. Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer. Cancer 2023 Oct 16. doi: 10.1002/cncr.35059.
PMID: 37843249